메뉴 건너뛰기




Volumn 102, Issue 2, 2007, Pages 821-822

Interleukin-6 does/does not have a beneficial role in insulin sensitivity and glucose homeostasis [5]

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; INTERLEUKIN 1; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; GLUCOSE;

EID: 33846878960     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.01353.2006     Document Type: Letter
Times cited : (8)

References (6)
  • 4
    • 0242299763 scopus 로고    scopus 로고
    • Chronic interleukin-6 (IL-6) treatment increased IL-6 secretion and induced insulin resistance in adipocyte: Prevention by rosiglitazone
    • Lagathu C, Bastard JP, Auclair M, Maachi M, Capeau J, Caron M. Chronic interleukin-6 (IL-6) treatment increased IL-6 secretion and induced insulin resistance in adipocyte: prevention by rosiglitazone. Biochem Biophys Res Commun 311: 372-379, 2003.
    • (2003) Biochem Biophys Res Commun , vol.311 , pp. 372-379
    • Lagathu, C.1    Bastard, J.P.2    Auclair, M.3    Maachi, M.4    Capeau, J.5    Caron, M.6
  • 5
    • 33947518747 scopus 로고    scopus 로고
    • Counterpoint: Interleukin-6 does not have a beneficial role in insulin sensitivity and glucose homeostasis
    • In press
    • Mooney RA. Counterpoint: Interleukin-6 does not have a beneficial role in insulin sensitivity and glucose homeostasis. J Appl Physiol. In press.
    • J Appl Physiol
    • Mooney, R.A.1
  • 6
    • 33846883060 scopus 로고    scopus 로고
    • Point: Interleukin-6 does have a beneficial role in insulin sensitivity and glucose homeostasis
    • In press
    • Pedersen BK, Febbraio MA. Point: Interleukin-6 does have a beneficial role in insulin sensitivity and glucose homeostasis. J Appl Physiol. In press.
    • J Appl Physiol
    • Pedersen, B.K.1    Febbraio, M.A.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.